Literature DB >> 26053613

The Australian 75+ Health Assessment: could it detect early functional decline better?

Karen Grimmer1, Kate Kennedy1, Steven Milanese1, Kay Price2, Debra Kay1.   

Abstract

OBJECTIVE: The aim of the present study was to identify opportunities to improve the reach and impact of the Australian Medicare 75+ Health Assessment (75+HA) to detect early functional decline (FD).
METHODS: A comparison of two published review articles produced two outputs: (1) assessments identified in the systematic review that underpinned the 75+HA items were ranked for evidence of effectiveness and compared with the volume of research into assessment areas identified by a recent review on indicators of early FD; and (2) items in the 75+HA were compared with those in the recent review.
RESULTS: The review underpinning the 75+HA found 19 assessment areas, with strongest evidence of effectiveness for vision/hearing, teeth/oral, balance/gait, cognitive and service use. The more recent review reported on six domains (eight subdomains) of FD assessment: physical and cognitive elements of the performance capacity domain were the least well assessed, whereas the most comprehensively assessed domains were health service use, performance capacity (mental subdomain), participation (motivation/volition subdomain) and demographics. The 75+HA addresses only some items related to early FD as identified by the recent literature.
CONCLUSION: Reassessment of the 75+HA with a view to including current evidence-based assessments for early FD is recommended. Updating the 75+HA items with ways to detect FD earlier may increase its relevance to Australia's ageing population.

Entities:  

Mesh:

Year:  2016        PMID: 26053613     DOI: 10.1071/AH15011

Source DB:  PubMed          Journal:  Aust Health Rev        ISSN: 0156-5788            Impact factor:   1.990


  1 in total

1.  Improving the delivery of primary care for older people.

Authors:  C Dimity Pond; Catherine Regan
Journal:  Med J Aust       Date:  2019-06-17       Impact factor: 7.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.